Global Pomalidomide API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Pomalidomide(CAS?19171-19-8) is a derivative of thalidomide marketed by Celgene.
LPI (LP Information)' newest research report, the “Pomalidomide API Industry Forecast” looks at past sales and reviews total world Pomalidomide API sales in 2022, providing a comprehensive analysis by region and market sector of projected Pomalidomide API sales for 2023 through 2029. With Pomalidomide API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pomalidomide API industry.
This Insight Report provides a comprehensive analysis of the global Pomalidomide API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pomalidomide API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pomalidomide API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pomalidomide API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pomalidomide API.
The global Pomalidomide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pomalidomide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pomalidomide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pomalidomide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pomalidomide API players cover Mylan, Dr. Reddy's Laboratories, Hetero Drugs, Mac-Chem Products (India) Pvt.Ltd, Shilpa Medicare, Veranova, Natco Pharma Limited, Mehta API and Symed Labs Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pomalidomide API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pomalidomide API market?
What factors are driving Pomalidomide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pomalidomide API market opportunities vary by end market size?
How does Pomalidomide API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Pomalidomide(CAS?19171-19-8) is a derivative of thalidomide marketed by Celgene.
LPI (LP Information)' newest research report, the “Pomalidomide API Industry Forecast” looks at past sales and reviews total world Pomalidomide API sales in 2022, providing a comprehensive analysis by region and market sector of projected Pomalidomide API sales for 2023 through 2029. With Pomalidomide API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pomalidomide API industry.
This Insight Report provides a comprehensive analysis of the global Pomalidomide API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pomalidomide API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pomalidomide API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pomalidomide API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pomalidomide API.
The global Pomalidomide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pomalidomide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pomalidomide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pomalidomide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pomalidomide API players cover Mylan, Dr. Reddy's Laboratories, Hetero Drugs, Mac-Chem Products (India) Pvt.Ltd, Shilpa Medicare, Veranova, Natco Pharma Limited, Mehta API and Symed Labs Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pomalidomide API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Above 98 %
- Above 99 %
- Capsules
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mylan
- Dr. Reddy's Laboratories
- Hetero Drugs
- Mac-Chem Products (India) Pvt.Ltd
- Shilpa Medicare
- Veranova
- Natco Pharma Limited
- Mehta API
- Symed Labs Limited
- Hangzhou Longshine Bio-Tech
- Guangzhou Tosun Pharmaceutical
- Sumar Biotech
- Deva Holding AS
What is the 10-year outlook for the global Pomalidomide API market?
What factors are driving Pomalidomide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pomalidomide API market opportunities vary by end market size?
How does Pomalidomide API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pomalidomide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pomalidomide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pomalidomide API by Country/Region, 2018, 2022 & 2029
2.2 Pomalidomide API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Pomalidomide API Sales by Type
2.3.1 Global Pomalidomide API Sales Market Share by Type (2018-2023)
2.3.2 Global Pomalidomide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pomalidomide API Sale Price by Type (2018-2023)
2.4 Pomalidomide API Segment by Application
2.4.1 Capsules
2.4.2 Others
2.5 Pomalidomide API Sales by Application
2.5.1 Global Pomalidomide API Sale Market Share by Application (2018-2023)
2.5.2 Global Pomalidomide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pomalidomide API Sale Price by Application (2018-2023)
3 GLOBAL POMALIDOMIDE API BY COMPANY
3.1 Global Pomalidomide API Breakdown Data by Company
3.1.1 Global Pomalidomide API Annual Sales by Company (2018-2023)
3.1.2 Global Pomalidomide API Sales Market Share by Company (2018-2023)
3.2 Global Pomalidomide API Annual Revenue by Company (2018-2023)
3.2.1 Global Pomalidomide API Revenue by Company (2018-2023)
3.2.2 Global Pomalidomide API Revenue Market Share by Company (2018-2023)
3.3 Global Pomalidomide API Sale Price by Company
3.4 Key Manufacturers Pomalidomide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pomalidomide API Product Location Distribution
3.4.2 Players Pomalidomide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POMALIDOMIDE API BY GEOGRAPHIC REGION
4.1 World Historic Pomalidomide API Market Size by Geographic Region (2018-2023)
4.1.1 Global Pomalidomide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pomalidomide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pomalidomide API Market Size by Country/Region (2018-2023)
4.2.1 Global Pomalidomide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pomalidomide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pomalidomide API Sales Growth
4.4 APAC Pomalidomide API Sales Growth
4.5 Europe Pomalidomide API Sales Growth
4.6 Middle East & Africa Pomalidomide API Sales Growth
5 AMERICAS
5.1 Americas Pomalidomide API Sales by Country
5.1.1 Americas Pomalidomide API Sales by Country (2018-2023)
5.1.2 Americas Pomalidomide API Revenue by Country (2018-2023)
5.2 Americas Pomalidomide API Sales by Type
5.3 Americas Pomalidomide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pomalidomide API Sales by Region
6.1.1 APAC Pomalidomide API Sales by Region (2018-2023)
6.1.2 APAC Pomalidomide API Revenue by Region (2018-2023)
6.2 APAC Pomalidomide API Sales by Type
6.3 APAC Pomalidomide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pomalidomide API by Country
7.1.1 Europe Pomalidomide API Sales by Country (2018-2023)
7.1.2 Europe Pomalidomide API Revenue by Country (2018-2023)
7.2 Europe Pomalidomide API Sales by Type
7.3 Europe Pomalidomide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pomalidomide API by Country
8.1.1 Middle East & Africa Pomalidomide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pomalidomide API Revenue by Country (2018-2023)
8.2 Middle East & Africa Pomalidomide API Sales by Type
8.3 Middle East & Africa Pomalidomide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pomalidomide API
10.3 Manufacturing Process Analysis of Pomalidomide API
10.4 Industry Chain Structure of Pomalidomide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pomalidomide API Distributors
11.3 Pomalidomide API Customer
12 WORLD FORECAST REVIEW FOR POMALIDOMIDE API BY GEOGRAPHIC REGION
12.1 Global Pomalidomide API Market Size Forecast by Region
12.1.1 Global Pomalidomide API Forecast by Region (2024-2029)
12.1.2 Global Pomalidomide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pomalidomide API Forecast by Type
12.7 Global Pomalidomide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Mylan
13.1.1 Mylan Company Information
13.1.2 Mylan Pomalidomide API Product Portfolios and Specifications
13.1.3 Mylan Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Mylan Main Business Overview
13.1.5 Mylan Latest Developments
13.2 Dr. Reddy's Laboratories
13.2.1 Dr. Reddy's Laboratories Company Information
13.2.2 Dr. Reddy's Laboratories Pomalidomide API Product Portfolios and Specifications
13.2.3 Dr. Reddy's Laboratories Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dr. Reddy's Laboratories Main Business Overview
13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 Hetero Drugs
13.3.1 Hetero Drugs Company Information
13.3.2 Hetero Drugs Pomalidomide API Product Portfolios and Specifications
13.3.3 Hetero Drugs Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hetero Drugs Main Business Overview
13.3.5 Hetero Drugs Latest Developments
13.4 Mac-Chem Products (India) Pvt.Ltd
13.4.1 Mac-Chem Products (India) Pvt.Ltd Company Information
13.4.2 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Portfolios and Specifications
13.4.3 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mac-Chem Products (India) Pvt.Ltd Main Business Overview
13.4.5 Mac-Chem Products (India) Pvt.Ltd Latest Developments
13.5 Shilpa Medicare
13.5.1 Shilpa Medicare Company Information
13.5.2 Shilpa Medicare Pomalidomide API Product Portfolios and Specifications
13.5.3 Shilpa Medicare Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shilpa Medicare Main Business Overview
13.5.5 Shilpa Medicare Latest Developments
13.6 Veranova
13.6.1 Veranova Company Information
13.6.2 Veranova Pomalidomide API Product Portfolios and Specifications
13.6.3 Veranova Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Veranova Main Business Overview
13.6.5 Veranova Latest Developments
13.7 Natco Pharma Limited
13.7.1 Natco Pharma Limited Company Information
13.7.2 Natco Pharma Limited Pomalidomide API Product Portfolios and Specifications
13.7.3 Natco Pharma Limited Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Natco Pharma Limited Main Business Overview
13.7.5 Natco Pharma Limited Latest Developments
13.8 Mehta API
13.8.1 Mehta API Company Information
13.8.2 Mehta API Pomalidomide API Product Portfolios and Specifications
13.8.3 Mehta API Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mehta API Main Business Overview
13.8.5 Mehta API Latest Developments
13.9 Symed Labs Limited
13.9.1 Symed Labs Limited Company Information
13.9.2 Symed Labs Limited Pomalidomide API Product Portfolios and Specifications
13.9.3 Symed Labs Limited Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Symed Labs Limited Main Business Overview
13.9.5 Symed Labs Limited Latest Developments
13.10 Hangzhou Longshine Bio-Tech
13.10.1 Hangzhou Longshine Bio-Tech Company Information
13.10.2 Hangzhou Longshine Bio-Tech Pomalidomide API Product Portfolios and Specifications
13.10.3 Hangzhou Longshine Bio-Tech Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hangzhou Longshine Bio-Tech Main Business Overview
13.10.5 Hangzhou Longshine Bio-Tech Latest Developments
13.11 Guangzhou Tosun Pharmaceutical
13.11.1 Guangzhou Tosun Pharmaceutical Company Information
13.11.2 Guangzhou Tosun Pharmaceutical Pomalidomide API Product Portfolios and Specifications
13.11.3 Guangzhou Tosun Pharmaceutical Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Guangzhou Tosun Pharmaceutical Main Business Overview
13.11.5 Guangzhou Tosun Pharmaceutical Latest Developments
13.12 Sumar Biotech
13.12.1 Sumar Biotech Company Information
13.12.2 Sumar Biotech Pomalidomide API Product Portfolios and Specifications
13.12.3 Sumar Biotech Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sumar Biotech Main Business Overview
13.12.5 Sumar Biotech Latest Developments
13.13 Deva Holding AS
13.13.1 Deva Holding AS Company Information
13.13.2 Deva Holding AS Pomalidomide API Product Portfolios and Specifications
13.13.3 Deva Holding AS Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Deva Holding AS Main Business Overview
13.13.5 Deva Holding AS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pomalidomide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pomalidomide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pomalidomide API by Country/Region, 2018, 2022 & 2029
2.2 Pomalidomide API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Pomalidomide API Sales by Type
2.3.1 Global Pomalidomide API Sales Market Share by Type (2018-2023)
2.3.2 Global Pomalidomide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pomalidomide API Sale Price by Type (2018-2023)
2.4 Pomalidomide API Segment by Application
2.4.1 Capsules
2.4.2 Others
2.5 Pomalidomide API Sales by Application
2.5.1 Global Pomalidomide API Sale Market Share by Application (2018-2023)
2.5.2 Global Pomalidomide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pomalidomide API Sale Price by Application (2018-2023)
3 GLOBAL POMALIDOMIDE API BY COMPANY
3.1 Global Pomalidomide API Breakdown Data by Company
3.1.1 Global Pomalidomide API Annual Sales by Company (2018-2023)
3.1.2 Global Pomalidomide API Sales Market Share by Company (2018-2023)
3.2 Global Pomalidomide API Annual Revenue by Company (2018-2023)
3.2.1 Global Pomalidomide API Revenue by Company (2018-2023)
3.2.2 Global Pomalidomide API Revenue Market Share by Company (2018-2023)
3.3 Global Pomalidomide API Sale Price by Company
3.4 Key Manufacturers Pomalidomide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pomalidomide API Product Location Distribution
3.4.2 Players Pomalidomide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POMALIDOMIDE API BY GEOGRAPHIC REGION
4.1 World Historic Pomalidomide API Market Size by Geographic Region (2018-2023)
4.1.1 Global Pomalidomide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pomalidomide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pomalidomide API Market Size by Country/Region (2018-2023)
4.2.1 Global Pomalidomide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pomalidomide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pomalidomide API Sales Growth
4.4 APAC Pomalidomide API Sales Growth
4.5 Europe Pomalidomide API Sales Growth
4.6 Middle East & Africa Pomalidomide API Sales Growth
5 AMERICAS
5.1 Americas Pomalidomide API Sales by Country
5.1.1 Americas Pomalidomide API Sales by Country (2018-2023)
5.1.2 Americas Pomalidomide API Revenue by Country (2018-2023)
5.2 Americas Pomalidomide API Sales by Type
5.3 Americas Pomalidomide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pomalidomide API Sales by Region
6.1.1 APAC Pomalidomide API Sales by Region (2018-2023)
6.1.2 APAC Pomalidomide API Revenue by Region (2018-2023)
6.2 APAC Pomalidomide API Sales by Type
6.3 APAC Pomalidomide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pomalidomide API by Country
7.1.1 Europe Pomalidomide API Sales by Country (2018-2023)
7.1.2 Europe Pomalidomide API Revenue by Country (2018-2023)
7.2 Europe Pomalidomide API Sales by Type
7.3 Europe Pomalidomide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pomalidomide API by Country
8.1.1 Middle East & Africa Pomalidomide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pomalidomide API Revenue by Country (2018-2023)
8.2 Middle East & Africa Pomalidomide API Sales by Type
8.3 Middle East & Africa Pomalidomide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pomalidomide API
10.3 Manufacturing Process Analysis of Pomalidomide API
10.4 Industry Chain Structure of Pomalidomide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pomalidomide API Distributors
11.3 Pomalidomide API Customer
12 WORLD FORECAST REVIEW FOR POMALIDOMIDE API BY GEOGRAPHIC REGION
12.1 Global Pomalidomide API Market Size Forecast by Region
12.1.1 Global Pomalidomide API Forecast by Region (2024-2029)
12.1.2 Global Pomalidomide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pomalidomide API Forecast by Type
12.7 Global Pomalidomide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Mylan
13.1.1 Mylan Company Information
13.1.2 Mylan Pomalidomide API Product Portfolios and Specifications
13.1.3 Mylan Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Mylan Main Business Overview
13.1.5 Mylan Latest Developments
13.2 Dr. Reddy's Laboratories
13.2.1 Dr. Reddy's Laboratories Company Information
13.2.2 Dr. Reddy's Laboratories Pomalidomide API Product Portfolios and Specifications
13.2.3 Dr. Reddy's Laboratories Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dr. Reddy's Laboratories Main Business Overview
13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 Hetero Drugs
13.3.1 Hetero Drugs Company Information
13.3.2 Hetero Drugs Pomalidomide API Product Portfolios and Specifications
13.3.3 Hetero Drugs Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hetero Drugs Main Business Overview
13.3.5 Hetero Drugs Latest Developments
13.4 Mac-Chem Products (India) Pvt.Ltd
13.4.1 Mac-Chem Products (India) Pvt.Ltd Company Information
13.4.2 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Portfolios and Specifications
13.4.3 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mac-Chem Products (India) Pvt.Ltd Main Business Overview
13.4.5 Mac-Chem Products (India) Pvt.Ltd Latest Developments
13.5 Shilpa Medicare
13.5.1 Shilpa Medicare Company Information
13.5.2 Shilpa Medicare Pomalidomide API Product Portfolios and Specifications
13.5.3 Shilpa Medicare Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shilpa Medicare Main Business Overview
13.5.5 Shilpa Medicare Latest Developments
13.6 Veranova
13.6.1 Veranova Company Information
13.6.2 Veranova Pomalidomide API Product Portfolios and Specifications
13.6.3 Veranova Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Veranova Main Business Overview
13.6.5 Veranova Latest Developments
13.7 Natco Pharma Limited
13.7.1 Natco Pharma Limited Company Information
13.7.2 Natco Pharma Limited Pomalidomide API Product Portfolios and Specifications
13.7.3 Natco Pharma Limited Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Natco Pharma Limited Main Business Overview
13.7.5 Natco Pharma Limited Latest Developments
13.8 Mehta API
13.8.1 Mehta API Company Information
13.8.2 Mehta API Pomalidomide API Product Portfolios and Specifications
13.8.3 Mehta API Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mehta API Main Business Overview
13.8.5 Mehta API Latest Developments
13.9 Symed Labs Limited
13.9.1 Symed Labs Limited Company Information
13.9.2 Symed Labs Limited Pomalidomide API Product Portfolios and Specifications
13.9.3 Symed Labs Limited Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Symed Labs Limited Main Business Overview
13.9.5 Symed Labs Limited Latest Developments
13.10 Hangzhou Longshine Bio-Tech
13.10.1 Hangzhou Longshine Bio-Tech Company Information
13.10.2 Hangzhou Longshine Bio-Tech Pomalidomide API Product Portfolios and Specifications
13.10.3 Hangzhou Longshine Bio-Tech Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hangzhou Longshine Bio-Tech Main Business Overview
13.10.5 Hangzhou Longshine Bio-Tech Latest Developments
13.11 Guangzhou Tosun Pharmaceutical
13.11.1 Guangzhou Tosun Pharmaceutical Company Information
13.11.2 Guangzhou Tosun Pharmaceutical Pomalidomide API Product Portfolios and Specifications
13.11.3 Guangzhou Tosun Pharmaceutical Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Guangzhou Tosun Pharmaceutical Main Business Overview
13.11.5 Guangzhou Tosun Pharmaceutical Latest Developments
13.12 Sumar Biotech
13.12.1 Sumar Biotech Company Information
13.12.2 Sumar Biotech Pomalidomide API Product Portfolios and Specifications
13.12.3 Sumar Biotech Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sumar Biotech Main Business Overview
13.12.5 Sumar Biotech Latest Developments
13.13 Deva Holding AS
13.13.1 Deva Holding AS Company Information
13.13.2 Deva Holding AS Pomalidomide API Product Portfolios and Specifications
13.13.3 Deva Holding AS Pomalidomide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Deva Holding AS Main Business Overview
13.13.5 Deva Holding AS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pomalidomide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pomalidomide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 6. Global Pomalidomide API Sales Market Share by Type (2018-2023)
Table 7. Global Pomalidomide API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pomalidomide API Revenue Market Share by Type (2018-2023)
Table 9. Global Pomalidomide API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 11. Global Pomalidomide API Sales Market Share by Application (2018-2023)
Table 12. Global Pomalidomide API Revenue by Application (2018-2023)
Table 13. Global Pomalidomide API Revenue Market Share by Application (2018-2023)
Table 14. Global Pomalidomide API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Pomalidomide API Sales by Company (2018-2023) & (Kg)
Table 16. Global Pomalidomide API Sales Market Share by Company (2018-2023)
Table 17. Global Pomalidomide API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pomalidomide API Revenue Market Share by Company (2018-2023)
Table 19. Global Pomalidomide API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Pomalidomide API Producing Area Distribution and Sales Area
Table 21. Players Pomalidomide API Products Offered
Table 22. Pomalidomide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pomalidomide API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Pomalidomide API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pomalidomide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pomalidomide API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pomalidomide API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Pomalidomide API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pomalidomide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pomalidomide API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pomalidomide API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Pomalidomide API Sales Market Share by Country (2018-2023)
Table 35. Americas Pomalidomide API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pomalidomide API Revenue Market Share by Country (2018-2023)
Table 37. Americas Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Pomalidomide API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Pomalidomide API Sales Market Share by Region (2018-2023)
Table 41. APAC Pomalidomide API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pomalidomide API Revenue Market Share by Region (2018-2023)
Table 43. APAC Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Pomalidomide API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Pomalidomide API Sales Market Share by Country (2018-2023)
Table 47. Europe Pomalidomide API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pomalidomide API Revenue Market Share by Country (2018-2023)
Table 49. Europe Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Pomalidomide API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Pomalidomide API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pomalidomide API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pomalidomide API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Pomalidomide API
Table 58. Key Market Challenges & Risks of Pomalidomide API
Table 59. Key Industry Trends of Pomalidomide API
Table 60. Pomalidomide API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pomalidomide API Distributors List
Table 63. Pomalidomide API Customer List
Table 64. Global Pomalidomide API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Pomalidomide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pomalidomide API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Pomalidomide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pomalidomide API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Pomalidomide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pomalidomide API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Pomalidomide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pomalidomide API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Pomalidomide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pomalidomide API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Pomalidomide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pomalidomide API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Pomalidomide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Mylan Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Pomalidomide API Product Portfolios and Specifications
Table 80. Mylan Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Dr. Reddy's Laboratories Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 84. Dr. Reddy's Laboratories Pomalidomide API Product Portfolios and Specifications
Table 85. Dr. Reddy's Laboratories Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Dr. Reddy's Laboratories Main Business
Table 87. Dr. Reddy's Laboratories Latest Developments
Table 88. Hetero Drugs Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 89. Hetero Drugs Pomalidomide API Product Portfolios and Specifications
Table 90. Hetero Drugs Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Hetero Drugs Main Business
Table 92. Hetero Drugs Latest Developments
Table 93. Mac-Chem Products (India) Pvt.Ltd Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 94. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Portfolios and Specifications
Table 95. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Mac-Chem Products (India) Pvt.Ltd Main Business
Table 97. Mac-Chem Products (India) Pvt.Ltd Latest Developments
Table 98. Shilpa Medicare Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 99. Shilpa Medicare Pomalidomide API Product Portfolios and Specifications
Table 100. Shilpa Medicare Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Shilpa Medicare Main Business
Table 102. Shilpa Medicare Latest Developments
Table 103. Veranova Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 104. Veranova Pomalidomide API Product Portfolios and Specifications
Table 105. Veranova Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Veranova Main Business
Table 107. Veranova Latest Developments
Table 108. Natco Pharma Limited Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 109. Natco Pharma Limited Pomalidomide API Product Portfolios and Specifications
Table 110. Natco Pharma Limited Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Natco Pharma Limited Main Business
Table 112. Natco Pharma Limited Latest Developments
Table 113. Mehta API Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 114. Mehta API Pomalidomide API Product Portfolios and Specifications
Table 115. Mehta API Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Mehta API Main Business
Table 117. Mehta API Latest Developments
Table 118. Symed Labs Limited Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 119. Symed Labs Limited Pomalidomide API Product Portfolios and Specifications
Table 120. Symed Labs Limited Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Symed Labs Limited Main Business
Table 122. Symed Labs Limited Latest Developments
Table 123. Hangzhou Longshine Bio-Tech Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 124. Hangzhou Longshine Bio-Tech Pomalidomide API Product Portfolios and Specifications
Table 125. Hangzhou Longshine Bio-Tech Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Hangzhou Longshine Bio-Tech Main Business
Table 127. Hangzhou Longshine Bio-Tech Latest Developments
Table 128. Guangzhou Tosun Pharmaceutical Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 129. Guangzhou Tosun Pharmaceutical Pomalidomide API Product Portfolios and Specifications
Table 130. Guangzhou Tosun Pharmaceutical Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. Guangzhou Tosun Pharmaceutical Main Business
Table 132. Guangzhou Tosun Pharmaceutical Latest Developments
Table 133. Sumar Biotech Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 134. Sumar Biotech Pomalidomide API Product Portfolios and Specifications
Table 135. Sumar Biotech Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Sumar Biotech Main Business
Table 137. Sumar Biotech Latest Developments
Table 138. Deva Holding AS Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 139. Deva Holding AS Pomalidomide API Product Portfolios and Specifications
Table 140. Deva Holding AS Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Deva Holding AS Main Business
Table 142. Deva Holding AS Latest Developments
Table 1. Pomalidomide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pomalidomide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 6. Global Pomalidomide API Sales Market Share by Type (2018-2023)
Table 7. Global Pomalidomide API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pomalidomide API Revenue Market Share by Type (2018-2023)
Table 9. Global Pomalidomide API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 11. Global Pomalidomide API Sales Market Share by Application (2018-2023)
Table 12. Global Pomalidomide API Revenue by Application (2018-2023)
Table 13. Global Pomalidomide API Revenue Market Share by Application (2018-2023)
Table 14. Global Pomalidomide API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Pomalidomide API Sales by Company (2018-2023) & (Kg)
Table 16. Global Pomalidomide API Sales Market Share by Company (2018-2023)
Table 17. Global Pomalidomide API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pomalidomide API Revenue Market Share by Company (2018-2023)
Table 19. Global Pomalidomide API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Pomalidomide API Producing Area Distribution and Sales Area
Table 21. Players Pomalidomide API Products Offered
Table 22. Pomalidomide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pomalidomide API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Pomalidomide API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pomalidomide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pomalidomide API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pomalidomide API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Pomalidomide API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pomalidomide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pomalidomide API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pomalidomide API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Pomalidomide API Sales Market Share by Country (2018-2023)
Table 35. Americas Pomalidomide API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pomalidomide API Revenue Market Share by Country (2018-2023)
Table 37. Americas Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Pomalidomide API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Pomalidomide API Sales Market Share by Region (2018-2023)
Table 41. APAC Pomalidomide API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pomalidomide API Revenue Market Share by Region (2018-2023)
Table 43. APAC Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Pomalidomide API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Pomalidomide API Sales Market Share by Country (2018-2023)
Table 47. Europe Pomalidomide API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pomalidomide API Revenue Market Share by Country (2018-2023)
Table 49. Europe Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Pomalidomide API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Pomalidomide API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pomalidomide API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pomalidomide API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pomalidomide API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Pomalidomide API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Pomalidomide API
Table 58. Key Market Challenges & Risks of Pomalidomide API
Table 59. Key Industry Trends of Pomalidomide API
Table 60. Pomalidomide API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pomalidomide API Distributors List
Table 63. Pomalidomide API Customer List
Table 64. Global Pomalidomide API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Pomalidomide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pomalidomide API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Pomalidomide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pomalidomide API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Pomalidomide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pomalidomide API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Pomalidomide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pomalidomide API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Pomalidomide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pomalidomide API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Pomalidomide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pomalidomide API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Pomalidomide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Mylan Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Pomalidomide API Product Portfolios and Specifications
Table 80. Mylan Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Dr. Reddy's Laboratories Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 84. Dr. Reddy's Laboratories Pomalidomide API Product Portfolios and Specifications
Table 85. Dr. Reddy's Laboratories Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Dr. Reddy's Laboratories Main Business
Table 87. Dr. Reddy's Laboratories Latest Developments
Table 88. Hetero Drugs Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 89. Hetero Drugs Pomalidomide API Product Portfolios and Specifications
Table 90. Hetero Drugs Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Hetero Drugs Main Business
Table 92. Hetero Drugs Latest Developments
Table 93. Mac-Chem Products (India) Pvt.Ltd Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 94. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Portfolios and Specifications
Table 95. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Mac-Chem Products (India) Pvt.Ltd Main Business
Table 97. Mac-Chem Products (India) Pvt.Ltd Latest Developments
Table 98. Shilpa Medicare Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 99. Shilpa Medicare Pomalidomide API Product Portfolios and Specifications
Table 100. Shilpa Medicare Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Shilpa Medicare Main Business
Table 102. Shilpa Medicare Latest Developments
Table 103. Veranova Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 104. Veranova Pomalidomide API Product Portfolios and Specifications
Table 105. Veranova Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Veranova Main Business
Table 107. Veranova Latest Developments
Table 108. Natco Pharma Limited Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 109. Natco Pharma Limited Pomalidomide API Product Portfolios and Specifications
Table 110. Natco Pharma Limited Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Natco Pharma Limited Main Business
Table 112. Natco Pharma Limited Latest Developments
Table 113. Mehta API Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 114. Mehta API Pomalidomide API Product Portfolios and Specifications
Table 115. Mehta API Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Mehta API Main Business
Table 117. Mehta API Latest Developments
Table 118. Symed Labs Limited Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 119. Symed Labs Limited Pomalidomide API Product Portfolios and Specifications
Table 120. Symed Labs Limited Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Symed Labs Limited Main Business
Table 122. Symed Labs Limited Latest Developments
Table 123. Hangzhou Longshine Bio-Tech Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 124. Hangzhou Longshine Bio-Tech Pomalidomide API Product Portfolios and Specifications
Table 125. Hangzhou Longshine Bio-Tech Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Hangzhou Longshine Bio-Tech Main Business
Table 127. Hangzhou Longshine Bio-Tech Latest Developments
Table 128. Guangzhou Tosun Pharmaceutical Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 129. Guangzhou Tosun Pharmaceutical Pomalidomide API Product Portfolios and Specifications
Table 130. Guangzhou Tosun Pharmaceutical Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. Guangzhou Tosun Pharmaceutical Main Business
Table 132. Guangzhou Tosun Pharmaceutical Latest Developments
Table 133. Sumar Biotech Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 134. Sumar Biotech Pomalidomide API Product Portfolios and Specifications
Table 135. Sumar Biotech Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Sumar Biotech Main Business
Table 137. Sumar Biotech Latest Developments
Table 138. Deva Holding AS Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors
Table 139. Deva Holding AS Pomalidomide API Product Portfolios and Specifications
Table 140. Deva Holding AS Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Deva Holding AS Main Business
Table 142. Deva Holding AS Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pomalidomide API
Figure 2. Pomalidomide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pomalidomide API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Pomalidomide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pomalidomide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Pomalidomide API Sales Market Share by Type in 2022
Figure 12. Global Pomalidomide API Revenue Market Share by Type (2018-2023)
Figure 13. Pomalidomide API Consumed in Capsules
Figure 14. Global Pomalidomide API Market: Capsules (2018-2023) & (Kg)
Figure 15. Pomalidomide API Consumed in Others
Figure 16. Global Pomalidomide API Market: Others (2018-2023) & (Kg)
Figure 17. Global Pomalidomide API Sales Market Share by Application (2022)
Figure 18. Global Pomalidomide API Revenue Market Share by Application in 2022
Figure 19. Pomalidomide API Sales Market by Company in 2022 (Kg)
Figure 20. Global Pomalidomide API Sales Market Share by Company in 2022
Figure 21. Pomalidomide API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pomalidomide API Revenue Market Share by Company in 2022
Figure 23. Global Pomalidomide API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pomalidomide API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pomalidomide API Sales 2018-2023 (Kg)
Figure 26. Americas Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pomalidomide API Sales 2018-2023 (Kg)
Figure 28. APAC Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pomalidomide API Sales 2018-2023 (Kg)
Figure 30. Europe Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pomalidomide API Sales 2018-2023 (Kg)
Figure 32. Middle East & Africa Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pomalidomide API Sales Market Share by Country in 2022
Figure 34. Americas Pomalidomide API Revenue Market Share by Country in 2022
Figure 35. Americas Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 36. Americas Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 37. United States Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pomalidomide API Sales Market Share by Region in 2022
Figure 42. APAC Pomalidomide API Revenue Market Share by Regions in 2022
Figure 43. APAC Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 44. APAC Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 45. China Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pomalidomide API Sales Market Share by Country in 2022
Figure 53. Europe Pomalidomide API Revenue Market Share by Country in 2022
Figure 54. Europe Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 55. Europe Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 56. Germany Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pomalidomide API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pomalidomide API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pomalidomide API in 2022
Figure 71. Manufacturing Process Analysis of Pomalidomide API
Figure 72. Industry Chain Structure of Pomalidomide API
Figure 73. Channels of Distribution
Figure 74. Global Pomalidomide API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pomalidomide API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pomalidomide API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pomalidomide API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pomalidomide API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pomalidomide API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pomalidomide API
Figure 2. Pomalidomide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pomalidomide API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Pomalidomide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pomalidomide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Pomalidomide API Sales Market Share by Type in 2022
Figure 12. Global Pomalidomide API Revenue Market Share by Type (2018-2023)
Figure 13. Pomalidomide API Consumed in Capsules
Figure 14. Global Pomalidomide API Market: Capsules (2018-2023) & (Kg)
Figure 15. Pomalidomide API Consumed in Others
Figure 16. Global Pomalidomide API Market: Others (2018-2023) & (Kg)
Figure 17. Global Pomalidomide API Sales Market Share by Application (2022)
Figure 18. Global Pomalidomide API Revenue Market Share by Application in 2022
Figure 19. Pomalidomide API Sales Market by Company in 2022 (Kg)
Figure 20. Global Pomalidomide API Sales Market Share by Company in 2022
Figure 21. Pomalidomide API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pomalidomide API Revenue Market Share by Company in 2022
Figure 23. Global Pomalidomide API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pomalidomide API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pomalidomide API Sales 2018-2023 (Kg)
Figure 26. Americas Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pomalidomide API Sales 2018-2023 (Kg)
Figure 28. APAC Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pomalidomide API Sales 2018-2023 (Kg)
Figure 30. Europe Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pomalidomide API Sales 2018-2023 (Kg)
Figure 32. Middle East & Africa Pomalidomide API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pomalidomide API Sales Market Share by Country in 2022
Figure 34. Americas Pomalidomide API Revenue Market Share by Country in 2022
Figure 35. Americas Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 36. Americas Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 37. United States Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pomalidomide API Sales Market Share by Region in 2022
Figure 42. APAC Pomalidomide API Revenue Market Share by Regions in 2022
Figure 43. APAC Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 44. APAC Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 45. China Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pomalidomide API Sales Market Share by Country in 2022
Figure 53. Europe Pomalidomide API Revenue Market Share by Country in 2022
Figure 54. Europe Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 55. Europe Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 56. Germany Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pomalidomide API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pomalidomide API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pomalidomide API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pomalidomide API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pomalidomide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pomalidomide API in 2022
Figure 71. Manufacturing Process Analysis of Pomalidomide API
Figure 72. Industry Chain Structure of Pomalidomide API
Figure 73. Channels of Distribution
Figure 74. Global Pomalidomide API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pomalidomide API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pomalidomide API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pomalidomide API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pomalidomide API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pomalidomide API Revenue Market Share Forecast by Application (2024-2029)
